Prevalence of Otorhinolaryngological Symptoms in Covid 19 Patients

Savtale, Saee; Hippargekar, Prashant; Bhise, Sudhir; Kothule, Shankar

doi:10.1007/s12070-021-02410-5

Cited by 35 publications

(56 citation statements)

References 20 publications

(24 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Lechien et al [41] had participants from France, Italy, Spain, Belgium, and Switzerland. There were six studies from Asia reporting from India [45,46], Pakistan [36], Turkey [49][50][51], and China [42]. The three additional studies were located in Russia [32]; Egypt [37]; and internationally, including the USA, UK, Northern Ireland, France, Canada, Spain, Netherlands, Ireland, Sweden, and other countries [18,33].…”

Section: Quality Analysis Of Case Reportsmentioning

confidence: 99%

“…Some studies excluded participants with comorbidities such as patients with hearing loss or at risk of having a hearing loss (e.g., noise exposure, surgeries, ototoxic medication, or diseases that may lead to hearing loss) [32,46,47]. Other comorbidity exclusion criteria included psychiatric disorders, cardiovascular or circulatory disorders [47], treatment with new drugs, chronic nasal problems, recent head trauma, brain or nose operations, and severe respiratory failure [45]. Davis et al [33] did not mention comorbidities; however, they excluded the following symptoms from the analysis: high blood pressure, low blood pressure, thrombosis, seizures, low oxygen levels, high blood sugar, and low blood sugar.…”

Section: Pre-existing Health Conditionsmentioning

confidence: 99%

“…This study did not directly investigate the COVID-19 disease but identified seven individuals reporting tinnitus and four with hearing loss after contracting COVID-19 from the sample of 237 reporting COVID-19 symptoms, out of the 3103 participants. Prevalence ranged from 0.35% [41] to 67% [45] for the disease related studies. The variability was found even in larger studies as Lechien et al [41] had a prevalence of 0.35% for 1420 participants and Davis et al [33] a prevalence of 34% for 3762 participants.…”

Section: Tinnitus Overviewmentioning

confidence: 99%

“…Of these, one participant reported that the tinnitus resolved over time. Savtale et al [45] revealed 120 patients (66.66%) amongst 188 self-reported new-onset tinnitus lasting 5 days (median, interquartile range [IQR] 4-6). Liang et al [42] revealed the average duration of tinnitus was 5 days.…”

Section: Tinnitus Characteristicmentioning

confidence: 99%

See 3 more Smart Citations

The Impact of COVID-19 and the Pandemic on Tinnitus: A Systematic Review

Beukes

Ulep

Eubank

et al. 2021

JCM

View full text Add to dashboard Cite

This review aimed to systematically review what has been published regarding tinnitus during the coronavirus disease 2019 (COVID-19) pandemic up to March 2021 by performing both narrative and quantitative meta-analyses. Of the 181 records identified, 33 met the inclusion criteria, which generally had a fair risk of overall bias. In the included, 28 studies focused on the impact of the COVID-19 virus on tinnitus and 5 studies focused on the impact of the pandemic on tinnitus. From the studies identifying the impact of COVID-19 on tinnitus, there were 17 cross-sectional studies (n = 8913) and 11 case series or case report studies (n = 35). There were 2 cross-sectional studies (n = 3232) and 3 pre-post-test design studies (n = 326) focusing on the impact of the pandemic on tinnitus. No consistent patterns were found regarding the presentation of the tinnitus or additional factors that could have tinnitus developing in the disease impact studies. For the pandemic impact studies, the associated stress and anxiety of the pandemic were consistently suggested to contribute to tinnitus experiences. The pooled estimated prevalence of tinnitus post COVID-19 was 8% (CI: 5 to 13%). Medical professionals should be aware that tinnitus might be more problematic following the pandemic or after having COVID-19.

show abstract

Section: Quality Analysis Of Case Reportsmentioning

confidence: 99%

Section: Pre-existing Health Conditionsmentioning

confidence: 99%

Section: Tinnitus Overviewmentioning

confidence: 99%

Section: Tinnitus Characteristicmentioning

confidence: 99%

See 2 more Smart Citations

The Impact of COVID-19 and the Pandemic on Tinnitus: A Systematic Review

Beukes

Ulep

Eubank

et al. 2021

JCM

View full text Add to dashboard Cite

show abstract

“…While fever (95%), fatigue (93%), shortness of breath (90%), cough (83%) were the most prominent symptoms of the patients at the time of admission, the common ENT symptoms were loss of smell (54%), decreased sense of taste (51%), hearing loss (50%), sore throat (47%) and tinnitus (39%). (20) In our study group, ENT-related symptoms such as tinnitus and hearing loss were among the rarely reported complaints.…”

Section: Discussionmentioning

confidence: 67%

Covid-19 Hastalarında Başvuru Şikayetleri

Şahin

Ocak²,

Demiral³

et al. 2021

Konuralp Tıp Dergisi

View full text Add to dashboard Cite

The aim of this study is to profile the complaints in the disease application using a symptom survey in patients presenting with the suspicion of COVID-19 disease and to determine the disease-specific and descriptive characteristics of the initial symptoms in those who were diagnosed with the disease. Methods: In this cross-sectional study, symptoms at first admission were questioned in adult patients who applied to the Covid Outpatient Clinic between 21 December 2020 -22 January 2021. A total of 43 complaints were analyzed in PCR test positive and negative patients. Results: 273 (62.0%) first application and 167 (38.0%) control applications were included in the study. The PCR test was positive in 16.5% of the first admissions. The most common complaints in the first admissions with positive PCR test were fatigue (73.0%), headache (64.9%), pain (32.2%), cough (56.8%), sore throat (51.4%), loss of appetite (45.9%) while 15.9% of them were asymptomatic. Odd's rates of significant complaints for PCR positivity were calculated as 2.607 for fever, 2.724 for anorexia, 2.051 for cough, 2.594 for loss of smell, and 2.243 for loss of strength. Conclusions: COVID-19 is a disease that affects many organs and systems. Comparing the admission symptoms with the PCR test results will contribute to the recognition of the disease at the initial stage. Fever, anorexia, cough, loss of smell and loss of strength were found to be the distinguishing complaints of PCR positivity in our study.

show abstract

Otologic and vestibular symptoms in COVID‐19: A scoping review

Ong

Cruz

2022

World j. otorhinolaryngol.-head neck surg.

View full text Add to dashboard Cite

Background Otologic and vestibular symptoms have been seen in patients confirmed to have COVID‐19 disease. Further discussion of these symptoms may provide insight into short‐ and long‐term management for these patients. Objective The aim of this review was to describe the otologic and vestibular symptoms that present in patients with COVID‐19. The primary outcomes of this review were onset, duration and clinical outcomes of these symptoms. Sources of Evidence Pub Med, APAMed Central, Herdin, CINAHL, Scopus, Springer Link, ProQuest Coronavirus Research Database, and Google Scholar were searched for the articles to be included. Eligibility Criteria Studies included were those involving adult patients diagnosed with COVID‐19 who experienced hearing loss, ear pain, ear discharge, otitis media, vertigo, or tinnitus. Studies were eligible for inclusion if there was a description of the otologic dysfunction, specifically onset, duration, or clinical outcomes. Results The majority of patients who experienced hearing loss (68%), tinnitus (88%), vertigo/dizziness (30%), ear pain (8%), and discharge (100%) did so within a month of experiencing the typical symptoms of COVID‐19. A majority also experienced complete resolution of their symptoms within 2 weeks. Standard treatment for COVID‐19 was usually provided but when specific diagnoses are made for these symptoms (e.g., sudden sensorineural hearing loss, otitis media, vestibular neuritis), they are treated in the same manner as one would for non‐COVID‐19 cases, in addition to the management for COVID‐19. In certain cases, there may be a need for additional work‐up to rule out other causes. Conclusions Otologic and vestibular symptoms were present in COVID‐19 patients, majority as part of the systemic nature of the disease. The onset, duration, and course were consistent with the natural history of a systemic viral infection. COVID‐19 should be considered in any patient with a new‐onset hearing loss, tinnitus, or vertigo/dizziness, even in the absence of infectious or respiratory symptoms.

show abstract

Prevalence of Otorhinolaryngological Symptoms in Covid 19 Patients

Cited by 35 publications

References 20 publications

The Impact of COVID-19 and the Pandemic on Tinnitus: A Systematic Review

The Impact of COVID-19 and the Pandemic on Tinnitus: A Systematic Review

Covid-19 Hastalarında Başvuru Şikayetleri

Otologic and vestibular symptoms in COVID‐19: A scoping review

Contact Info

Product

Resources

About